Malassezia Folliculitis
Conditions
Interventions
Experimental group:30% supramolecular salicylic acid+supramolecular active zinc
Sponsors
Dermatology Hospital of Southern Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Men and women are not limited, and aged 18 to 65 years; 2. Those who have been detected as Malassezia folliculitis; 3. Grade II to III folliculitis that occurs on the chest or back; 4. Participate voluntarily and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Suffering from other skin diseases that may aggravate the disease, or the researchers believe that the disease may affect the judgment of the test results; 2. Those who are allergic to the test product or have a high-sensitivity constitution; 3. Pregnancy and lactation patients; 4. Patients who have taken oral antifungal drugs (or have used antifungal drugs within 2 months) within 4 months before the trial; patients who have taken oral antibiotics, glucocorticoids and other drugs for folliculitis within 4 weeks; or have used Patients with physical therapy for folliculitis; or patients treated with salicylic acid and fruit acid; or patients who have used other topical drugs for the treatment of folliculitis within 2 weeks; 5. Patients with a history of injection or surgery in the affected area 2 months before the trial; 6. Patients with immunodeficiency diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skin lesion count;Malassezia microscopic examination; | — |
Secondary
| Measure | Time frame |
|---|---|
| Recurrence rate;Patient self-evaluation; | — |
Countries
China
Contacts
Public ContactLiu Zhenfeng
Dermatology Hospital of Southern Medical University
Outcome results
None listed